Eisai
4523.T
#2489
Rank
NZ$12.59 B
Marketcap
NZ$44.65
Share price
-2.03%
Change (1 day)
-1.43%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): NZ$1.42

According to Eisai's latest financial reports the company's current EPS (TTM) is NZ$1.48. an increase over its 2024 EPS that were of NZ$1.67.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025NZ$1.8711.85%
2024NZ$1.67-32.63%
2023NZ$2.485.52%
2022NZ$2.35-74.01%
2021NZ$9.03-66.58%
2020NZ$27.0298.24%
2019NZ$13.6317.01%
2018NZ$11.6537.78%
2017NZ$8.46-27.62%
2016NZ$11.6835.33%
2015NZ$8.63-2.82%
2014NZ$8.88-27.66%
2013NZ$12.28-27.49%
2012NZ$16.94-12.67%
2011NZ$19.4088.08%
2010NZ$10.31-11.06%
2009NZ$11.60-390.15%
2008NZ-$4.00-127.78%
2007NZ$14.3911.78%
2006NZ$12.874.38%
2005NZ$12.337.4%
2004NZ$11.4843.03%
2003NZ$8.0325.09%
2002NZ$6.4252.67%
2001NZ$4.2069.76%
2000NZ$2.48